Healthcare Stocks Outlook Based on Stock Market Algorithm: Returns up to 19.61% in 7 Days

Healthcare Stocks Outlook

This Healthcare Stocks Package is designed for investors and analysts who need predictions of the best shares within the Healthcare Sector. It includes 20 stocks with bullish and bearish signals and indicates the best healthcare stocks to buy and sell:

  • Top 10 HealthCare stocks for the long position
  • Top 10 HealthCare stocks for the short position

Package Name: HealthCare Stocks
Recommended Positions: Long
Forecast Length: 7 Days (04/09/2018 – 04/16/2018)
I Know First Average: 6.45%
Healthcare Stocks Outlook

Several predictions in this short-term 7 Days forecast saw significant returns. The algorithm had correctly predicted 8 out 10 stock movements. NSTG was the top performing prediction with a return of 19.61%. PTN and XON saw outstanding returns of 17.07% and 10.29%. With these notable trade returns, the package itself registered an average return of 6.45% compared to the S&P 500’s return of 2.82% for the same period.

NanoString Technologies, Inc., incorporated on June 20, 2003, develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company’s nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use. The Company’s molecular diagnostic product Prosigna Breast Cancer Assay, or Prosigna, provides an assessment of a patient’s risk of recurrence for breast cancer. As of December 31, 2016, the Company had an installed base of approximately 480 systems, which its customers have used to publish over 1,450 peer-reviewed papers.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.